Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At - Home Measures

NCT05137665 is registered in ClinicalTrials.gov with Target ALS Foundation, Inc. as lead sponsor.

NCT NCT05137665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05137665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At - Home Measures
Lead sponsor
Target ALS Foundation, Inc.
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2021
Completion date
December 31, 2031
Enrollment
1,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, degenerative disorder, motor neuron disease, movement disorders